Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
2.205
-0.055 (-2.43%)
Mar 31, 2025, 3:11 PM EDT - Market open

Heron Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3362332552979311,923
Upgrade
Market Cap Growth
-8.79%-8.79%-14.16%-68.06%-51.60%-9.13%
Upgrade
Enterprise Value
4513403583338921,690
Upgrade
Last Close Price
2.261.531.702.509.1321.16
Upgrade
PS Ratio
2.391.612.012.7610.7821.69
Upgrade
PB Ratio
-9.89-6.91-7.5121.9012.008.13
Upgrade
P/TBV Ratio
---21.9012.008.13
Upgrade
EV/Sales Ratio
3.132.362.823.1010.3419.06
Upgrade
Debt / Equity Ratio
-5.28-5.28-5.2911.602.060.10
Upgrade
Asset Turnover
0.630.630.540.390.260.21
Upgrade
Inventory Turnover
1.161.162.072.593.896.27
Upgrade
Quick Ratio
1.511.511.761.662.722.44
Upgrade
Current Ratio
2.292.292.372.503.583.07
Upgrade
Return on Equity (ROE)
----399.43%-140.53%-70.99%
Upgrade
Return on Assets (ROA)
-3.16%-3.16%-24.56%-38.01%-41.04%-32.11%
Upgrade
Return on Capital (ROIC)
-4.97%-4.97%-36.71%-51.84%-54.31%-40.63%
Upgrade
Earnings Yield
-4.08%-5.84%-43.34%-61.24%-23.71%-11.82%
Upgrade
FCF Yield
-7.28%-10.41%-23.65%-50.04%-22.18%-9.97%
Upgrade
Buyback Yield / Dilution
-10.36%-10.36%-26.87%-10.57%-8.48%-11.00%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q